Pharma Procurement Strategist
Enregistrez cette offre et organisez votre recherche
Créez un compte gratuit pour enregistrer des offres d'emploi, créer des alertes et revenir à cette liste depuis votre tableau de bord.
Akkodis Belgium is seeking a Strategic Procurement & Buying Specialist to optimise procurement processes for a key pharmaceutical client. You will manage supplier relationships across engineering, production, packaging, construction and capital service categories.
The role requires a bachelor’s degree in a related field, proven buying experience, strong negotiation skills and proficiency with SAP. Fluency in English and Dutch is mandatory, and experience with AI-driven procurement is a plus.
-
Pharma Procurement Strategist | AI-Driven Sourcing
Il y a 3 jours
Vlaanderen, Vlaanderen, Belgique Akkodis Temps plein 50 000 € - 70 000 € ContratAkkodis Belgium is hiring a Strategic Procurement & Buying Specialist to lead supplier sourcing, negotiate terms and develop category strategies across a leading pharmaceutical site.You will review procurement schedules, process orders and invoices, drive cost savings through competitive bidding, and ensure regulatory compliance. Fluency in English and...
-
Account Manager
Il y a 4 jours
West-Vlaanderen, West-Vlaanderen, Belgique skinn Temps plein 48 000 € - 70 000 € ContratWe are looking for a senior, sales-driven Account Manager with a strong commercial mindset and a clear affinity for branding, design and strategy. You work with ambitious, often international clients and build long‑term relationships at a senior level.You are the main point of contact for clients, think proactively and combine commercial drive with a sharp...
-
Head of Specialized Sourcing
Il y a 5 jours
Oost-Vlaanderen, Oost-Vlaanderen, Belgique argenx SE Temps plein 150 000 € - 210 000 € ContratJoin us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...
